Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Stock Passes Below 200-Day Moving Average – Should You Sell?

Shares of Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $6.64 and traded as low as $6.06. Neuberger Berman High Yield Strategies Fund shares last traded at $6.10, with a volume of 114,093 shares.

Neuberger Berman High Yield Strategies Fund Price Performance

The company’s fifty day simple moving average is $6.15 and its 200 day simple moving average is $6.63.

Neuberger Berman High Yield Strategies Fund Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Monday, August 31st. Stockholders of record on Monday, August 17th will be given a $0.0905 dividend. The ex-dividend date of this dividend is Monday, August 17th. This represents a c) annualized dividend and a dividend yield of 17.8%.

Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. EP Wealth Advisors LLC purchased a new position in Neuberger Berman High Yield Strategies Fund during the second quarter valued at $71,000. Cura Wealth Advisors LLC bought a new position in shares of Neuberger Berman High Yield Strategies Fund in the 2nd quarter worth about $77,000. Mercer Global Advisors Inc. ADV purchased a new position in Neuberger Berman High Yield Strategies Fund during the 3rd quarter valued at about $80,000. Integrity Advisory Solutions LLC purchased a new position in Neuberger Berman High Yield Strategies Fund during the 4th quarter valued at about $81,000. Finally, XTX Topco Ltd bought a new stake in Neuberger Berman High Yield Strategies Fund during the second quarter worth about $113,000.

Neuberger Berman High Yield Strategies Fund Company Profile

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.